TRANSLATIONAL FINDINGS FROM THE PHASE 2 LUMINICE-203 STUDY OF ACIMTAMIG (AFM13) IN COMBINATION WITH ALLONK&#174; (AB-101) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

AlloNK (GCC4001) - Artiva Biotherapeutics

acimtamig (AFM13) - Affimed

https://library.ehaweb.org/eha/2025/eha2025-congress/4161073/joseph.maakaron.translational.findings.from.the.phase.2.luminice-203.study.of.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Amedia%3D3%2Ace_id%3D2882%2Aot_id%3D31572%2Amarker%3D5844%2Afeatured%3D19595

Alexandra Vasile; Joseph Maakaron; Tatyana Feldman; Todd A. Fehniger; Gunjan Shah; Amitkumar Mehta; Dipenkumar Modi; Alison Moskowitz; Andre Overesch; Lydia Wunderle; Michael Emig; Gina Chu; Heather Raymon; Thorsten Graef; Kerstin Pietzko

May 16, 2025